explore -WSS

explore

author：fashion 2025-10-01 23:07:02 - browse：962

Adam's take main illustration — Molly Ferguson/STAT

Thoughts about Cytokinetics after Wednesday night’s financing announcement:

1. Management is raising $500 million at $51 per share, when the stock was at $45 per share before the aficamtem study readout in December. That’s shocking. Somehow, management has not only removed all the M&A premium from the stock, but much or most of aficamtem’s value, too.

2. Omecamtiv’s resurrection: Are you kidding me? No one thinks bringing back this heart failure drug is a good idea, except management. Making it worse, the terms of the Royalty Pharma loan are, again, shocking. All the risk is borne by Cytokinetics. Royalty, in fact, may do better if omecamtiv fails.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： The Karikó problem: Lessons for funding basic research

knowledge

WSS

VC firm RA Capital starts a new synthetic biology incubator

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Study points to new risk in gene therapy death of Terry Horgan

The biotech scorecard for Q4: 16 stock

Health insurers' Q3 question: how much care are people getting?

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Supreme Court strikes down use of affirmative action

The Karikó problem: Lessons for funding basic research

DIEP, the 'gold standard' of breast reconstruction, is under threat

CDC picks Alphabet's Verily for wasterwater surveillance contract

Affirmative action in medical school literally saved lives

What will Novo Nordisk's VC do with its influx of cash?

What does generative AI mean for health care? We asked experts

Biden jokes that Republicans may impeach him because inflation is starting to cool down

hotspot

Health insurers' Q3 question: how much care are people getting?

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Stop Congress from blocking public access to science

Ford recalls 870K F

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Health insurers' Q3 question: how much care are people getting?

focus

knowledge

focus

hotspot